202 related articles for article (PubMed ID: 33634921)
1. Predicting Neuroimaging Biomarkers for Antidepressant Selection in Early Treatment of Depression.
Xue L; Pei C; Wang X; Wang H; Tian S; Yao Z; Lu Q
J Magn Reson Imaging; 2021 Aug; 54(2):551-559. PubMed ID: 33634921
[TBL] [Abstract][Full Text] [Related]
2. Prediction of early improvement of major depressive disorder to antidepressant medication in adolescents with radiomics analysis after ComBat harmonization based on multiscale structural MRI.
Ma H; Zhang D; Wang Y; Ding Y; Yang J; Li K
BMC Psychiatry; 2023 Jun; 23(1):466. PubMed ID: 37365541
[TBL] [Abstract][Full Text] [Related]
3. Ensemble Learning for Early-Response Prediction of Antidepressant Treatment in Major Depressive Disorder.
Pei C; Sun Y; Zhu J; Wang X; Zhang Y; Zhang S; Yao Z; Lu Q
J Magn Reson Imaging; 2020 Jul; 52(1):161-171. PubMed ID: 31859419
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis of Major Depressive Disorder Using Machine Learning Based on Multisequence MRI Neuroimaging Features.
Li Q; Dong F; Gai Q; Che K; Ma H; Zhao F; Chu T; Mao N; Wang P
J Magn Reson Imaging; 2023 Nov; 58(5):1420-1430. PubMed ID: 36797655
[TBL] [Abstract][Full Text] [Related]
5. Prediction of remission among patients with a major depressive disorder based on the resting-state functional connectivity of emotion regulation networks.
Wu H; Liu R; Zhou J; Feng L; Wang Y; Chen X; Zhang Z; Cui J; Zhou Y; Wang G
Transl Psychiatry; 2022 Sep; 12(1):391. PubMed ID: 36115833
[TBL] [Abstract][Full Text] [Related]
6. Abnormal Hippocampal Subfields May Be Potential Predictors of Worse Early Response to Antidepressant Treatment in Drug-Naïve Patients With Major Depressive Disorder.
Hu X; Zhang L; Hu X; Lu L; Tang S; Li H; Bu X; Gong Q; Huang X
J Magn Reson Imaging; 2019 Jun; 49(6):1760-1768. PubMed ID: 30295348
[TBL] [Abstract][Full Text] [Related]
7. Influence and interaction of genetic, cognitive, neuroendocrine and personalistic markers to antidepressant response in Chinese patients with major depression.
Bi Y; Ren D; Guo Z; Ma G; Xu F; Chen Z; An L; Zhang N; Ji L; Yuan F; Liu L; Hou B; Yang F; Yu S; Yi Z; Xu Y; He L; Sun X; Dong Z; Wu S; Zhao L; Cai C; Li X; Yu T; Shi Y; He G
Prog Neuropsychopharmacol Biol Psychiatry; 2021 Jan; 104():110036. PubMed ID: 32702381
[TBL] [Abstract][Full Text] [Related]
8. Shared and unique imaging-derived endo-phenotypes of two typical antidepressant-applicative depressive patients.
Xue L; Shao J; Wang H; Wang X; Zhu R; Yao Z; Lu Q
Eur Radiol; 2023 Jan; 33(1):645-655. PubMed ID: 35980436
[TBL] [Abstract][Full Text] [Related]
9. An Investigation into the Association Between Dopamine Receptor D1 Multilocus Genetic Variation, Multiparametric Magnetic Resonance Imaging, and Antidepressant Treatment.
Sun Y; Wang X; Tian S; Chen Z; Wang H; Xue L; Yan R; Yao Z; Lu Q
J Magn Reson Imaging; 2022 Jul; 56(1):282-290. PubMed ID: 34870351
[TBL] [Abstract][Full Text] [Related]
10. Amygdala Reactivity to Emotional Faces in the Prediction of General and Medication-Specific Responses to Antidepressant Treatment in the Randomized iSPOT-D Trial.
Williams LM; Korgaonkar MS; Song YC; Paton R; Eagles S; Goldstein-Piekarski A; Grieve SM; Harris AW; Usherwood T; Etkin A
Neuropsychopharmacology; 2015 Sep; 40(10):2398-408. PubMed ID: 25824424
[TBL] [Abstract][Full Text] [Related]
11. Development of Neuroimaging-Based Biomarkers in Major Depression.
Han KM; Ham BJ; Kim YK
Adv Exp Med Biol; 2021; 1305():85-99. PubMed ID: 33834396
[TBL] [Abstract][Full Text] [Related]
12. Establishing moderators and biosignatures of antidepressant response in clinical care (EMBARC): Rationale and design.
Trivedi MH; McGrath PJ; Fava M; Parsey RV; Kurian BT; Phillips ML; Oquendo MA; Bruder G; Pizzagalli D; Toups M; Cooper C; Adams P; Weyandt S; Morris DW; Grannemann BD; Ogden RT; Buckner R; McInnis M; Kraemer HC; Petkova E; Carmody TJ; Weissman MM
J Psychiatr Res; 2016 Jul; 78():11-23. PubMed ID: 27038550
[TBL] [Abstract][Full Text] [Related]
13. Prediction of nonremission to antidepressant therapy using diffusion tensor imaging.
Grieve SM; Korgaonkar MS; Gordon E; Williams LM; Rush AJ
J Clin Psychiatry; 2016 Apr; 77(4):e436-43. PubMed ID: 27137427
[TBL] [Abstract][Full Text] [Related]
14. Cortical thickening in remitters compared to non-remitters with major depressive disorder following 8-week antidepressant treatment.
Saricicek Aydogan A; Oztekin E; Esen ME; Dusmez S; Gelal F; Besiroğlu L; Zorlu N
Acta Psychiatr Scand; 2019 Sep; 140(3):217-226. PubMed ID: 31250445
[TBL] [Abstract][Full Text] [Related]
15. Partly recovery and compensation in anterior cingulate cortex after SSRI treatment-evidence from multi-voxel pattern analysis over resting state fMRI in depression.
Zhang Y; Shao J; Wang X; Pei C; Zhang S; Yao Z; Lu Q
J Affect Disord; 2023 Jan; 320():404-412. PubMed ID: 36179779
[TBL] [Abstract][Full Text] [Related]
16. Hippocampal and parahippocampal volume and function predict antidepressant response in patients with major depression: A multimodal neuroimaging study.
Paolini M; Harrington Y; Colombo F; Bettonagli V; Poletti S; Carminati M; Colombo C; Benedetti F; Zanardi R
J Psychopharmacol; 2023 Nov; 37(11):1070-1081. PubMed ID: 37589290
[TBL] [Abstract][Full Text] [Related]
17. Discovering biomarkers for antidepressant response: protocol from the Canadian biomarker integration network in depression (CAN-BIND) and clinical characteristics of the first patient cohort.
Lam RW; Milev R; Rotzinger S; Andreazza AC; Blier P; Brenner C; Daskalakis ZJ; Dharsee M; Downar J; Evans KR; Farzan F; Foster JA; Frey BN; Geraci J; Giacobbe P; Feilotter HE; Hall GB; Harkness KL; Hassel S; Ismail Z; Leri F; Liotti M; MacQueen GM; McAndrews MP; Minuzzi L; Müller DJ; Parikh SV; Placenza FM; Quilty LC; Ravindran AV; Salomons TV; Soares CN; Strother SC; Turecki G; Vaccarino AL; Vila-Rodriguez F; Kennedy SH;
BMC Psychiatry; 2016 Apr; 16():105. PubMed ID: 27084692
[TBL] [Abstract][Full Text] [Related]
18. Diffusion tensor imaging predictors of treatment outcomes in major depressive disorder.
Korgaonkar MS; Williams LM; Song YJ; Usherwood T; Grieve SM
Br J Psychiatry; 2014 Oct; 205(4):321-8. PubMed ID: 24970773
[TBL] [Abstract][Full Text] [Related]
19. Neuroimaging biomarkers as predictors of treatment outcome in Major Depressive Disorder.
Fonseka TM; MacQueen GM; Kennedy SH
J Affect Disord; 2018 Jun; 233():21-35. PubMed ID: 29150145
[TBL] [Abstract][Full Text] [Related]
20. Does pretreatment testing for serotonin transporter polymorphisms lead to earlier effects of drug treatment in patients with major depression? A decision-analytic model.
Smits KM; Smits LJ; Schouten JS; Peeters FP; Prins MH
Clin Ther; 2007 Apr; 29(4):691-702. PubMed ID: 17617292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
